Patient Assistance

Takeda does not charge patients a fee for its assistance. Takeda is not affiliated with third parties who charge a fee for assistance with enrollment or medication refills. If you are being charged a monthly fee for support from Takeda, the organization billing you is not Takeda and you are being charged for support that Takeda can provide to you directly at no cost.

At Takeda, we believe all patients should have access to the medication prescribed by their healthcare professionals. We also understand that some patients may have financial situations that make it difficult to pay for their prescriptions. Help At Hand provides assistance for people who have no insurance or who do not have enough insurance and need help getting their Takeda medicines.

New COVID-19 pandemic Job Loss Provision is available for Takeda's Help at Hand program to help commercially insured, eligible patients who have lost their job and are experiencing a financial hardship. Eligible patients may receive 6 months of free Takeda medication.

To apply:

• Download the Help at Hand application (below). Please note that both you and your healthcare provider must complete the application
• In Section 4 of the application, check the box that states, "Have you recently lost your job and are experiencing financial hardship?''
• In the same section (Section 4), check the box that states, "If yes, please attach proof of job termination or unemployment."
• Fax or mail the completed application, along with your proof of job termination or unemployment, to the address or fax number indicated on the application

Download the "Help At Hand" application here.

For additional information, please call 1-800-830-9159.

TAKEDA IS DEDICATED TO ASSISTING PATIENTS WITH LIMITED FINANCIAL RESOURCES. IF YOU DON’T HAVE PRESCRIPTION INSURANCE OR ARE HAVING TROUBLE AFFORDING YOUR MEDICINES, TAKEDA MAY BE ABLE TO HELP.

THE MEDICINES AVAILABLE THROUGH THE TAKEDA HELP AT HAND PATIENT ASSISTANCE & SUPPORT PROGRAM ARE:

AMITIZA
(LUBIPROSTONE)
CAPSULES
Click for Prescribing Information

CARBATROL®
(CARBAMAZEPINE)
EXTENDED-RELEASE CAPSULES
Click for Prescribing Information including Warning about Serious Dermatologic Reactions and HLA-B*1502 Allele and Aplastic Anemia and Agranulocytosis

COLCRYS (COLCHICINE, USP) TABLETS
Click for Prescribing Information and Medication Guide

DEXILANT
(DEXLANSOPRAZOLE) DELAYED-RELEASE CAPSULES
Click for Prescribing Information and Medication Guide

FOSRENOL® (LANTHANUM
CARBONATE) CHEWABLE
TABLETS, ORAL POWDER
Click for Prescribing Information and Medication Guide

INTUNIV® (GUANFACINE)
EXTENDED-RELEASE TABLETS
Click for Prescribing Information

KAZANO (ALOGLIPTIN AND
METFORMIN HCL) TABLETS

Click for Prescribing Information and Medication Guide, including warning about Lactic Acidosis

LIALDA® (MESALAMINE)
DELAYED-RELEASE TABLETS
Click for Prescribing Information

MOTEGRITY®
(PRUCALOPRIDE) TABLETS
Click for Prescribing Information

MYDAYIS® (MIXED SALTS OF A
SINGLE-ENTITY AMPHETAMINE
PRODUCT) EXTENDED-RELEASE
CAPSULES CII
Click for Prescribing Information and
Medication Guide, including Warning
about Abuse and Dependence

NESINA (ALOGLIPTIN)
TABLETS AND
MEDICATION GUIDE
Click for Prescribing Information
and Medication Guide

OSENI (ALOGLIPTIN AND
PIOGLITAZONE) TABLETS
Click for Prescribing Information
and Medication Guide, including
Warning about Congestive Heart Failure

PENTASA® (MESALAMINE)
EXTENDED RELEASE CAPSULES
Click for Prescribing Information

PREVACID SOLUTAB
(LANSOPRAZOLE)
DELAYED-RELEASE ORALLY
DISINTEGRATING TABLETS
Click for Prescribing Information and Medication Guide

ROZEREM (RAMELTEON)
TABLETS
Click for Prescribing Information and Medication Guide

TRINTELLIX
(VORTIOXETINE) TABLETS
Click for Prescribing Information
and Medication Guide, including
Warning about Suicidal Thoughts
and Behaviors

VYVANSE®
(LISDEXAMFETAMINE
DIMESYLATE) CAPSULES,
CHEWABLE TABLETS CII
Click for Prescribing Information
and Medication Guide, including
Warning about Abuse and Dependence

AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

CARBATROL® is a registered trademark of Shire LLC.

COLCRYS is a trademark of Takeda Pharmaceuticals U.S.A., Inc., registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

DEXILANT and DEXILANT (with design) are trademarks of Takeda Pharmaceuticals U.S.A., Inc., registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

FOSRENOL® is registered in the U.S. Patent and Trademark Office. © 2016 Shire US Inc.

INTUNIV® is a registered trademark of Shire LLC.

LIALDA® is a registered trademark of Shire LLC.

MOTEGRITY® is a registered trademark of Shire LLC, a wholly-owned, indirect subsidiary of Shire plc.

MYDAYIS is a trademark of Shire LLC.

NESINA, OSENI and KAZANO are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

PENTASA is a registered trademark of Ferring B.V. © 2019 Takeda Pharmaceutical Company Limited.

PREVACID is a trademark registered in the U.S. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals U.S.A., Inc. and used under license by Takeda Pharmaceuticals America, Inc.

ROZEREM is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

TRINTELLIX is a trademark of H. Lundbeck A/S, trademarks are used under license by Takeda Pharmaceuticals America, Inc.

VYVANSE® is a registered trademark of Shire LLC. © 2017 Shire US Inc.

This program, as well as all Takeda Pharmaceuticals America, Inc. programs, can be discontinued or changed at any time without notice at the discretion of Takeda Pharmaceuticals America, Inc.

Some restrictions apply.